| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $565K | — | -95.8% |
| Cost of Revenue | $544K | — | -91.5% |
| Gross Profit | $21K | — | -99.7% |
| R&D Expense | $12.8M | — | +40.2% |
| SG&A Expense | $24.8M | — | +6.8% |
| Operating Income | -$57.5M | — | -62.8% |
| Pre-tax Income | -$46.7M | — | -55.3% |
| Net Income | -$44.0M | — | -214.3% |
| EPS (Basic) | -$0.14 | — | -27.3% |
| EPS (Diluted) | -$0.14 | — | -27.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $341.1M | -59.2% | -30.6% |
| Short-term Investments | $549.0M | +31.4% | +1730.0% |
| Accounts Receivable | $8.5M | +1.1% | -36.5% |
| Current Assets | $908.5M | -28.6% | +67.2% |
| Total Assets | $1.15B | -18.7% | +85.8% |
| Current Liabilities | $30.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$314.7M | — | -1281.0% |
| Capital Expenditures | $1.5M | — | +2171.6% |
| Investing Cash Flow | -$218.4M | — | -2298.8% |
| Financing Cash Flow | $37.8M | — | -63.2% |
| Free Cash Flow | -$316.2M | — | -1283.6% |
| -64.5% |
| Total Liabilities | $38.4M | -87.1% | -56.6% |
| Stockholders' Equity | $1.17B | -0.2% | +65.7% |